3(10): p. 1148- 1157. Memorial Sloan Kettering Cancer Center IRB Number: 17- 358 A(7) Approval date: 25 -Feb-2022 Page 51 of 51 Version: 2/26/16 20. Vandeveer, A., et al., Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor. Journal for ImmunoTherapy of Cancer, 2015. 3(2): p.